Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
Jacques Maas, Head Center for Reproductive Medicine at Maastricht UMC+, shared a post on LinkedIn:
“When two research schools of Maastricht University Faculty of Health, Medicine and Life Sciences and Maastricht UMC+: MERLN Institute for Technology-Inspired Regenerative Medicine and GROW – Research Institute for Oncology and Reproduction find each other and utilize long-standing, fruitful collaborations in the Netherlands in the field of endometriosis and adenomyosis, the impossible apparently becomes possible.
Roman Truckenmüller, Paul Wieringa, Niloofar Tahmasebi, and Erik Vrij have been awarded the prestigious NWO (Dutch Research Council) Perspective Grant for the project ‘FEMCHIP – Tackling endometriosis and adenomyosis through improved clinical diagnostics and human in vitro models to unlock understanding and therapy development’.
FEMCHIP aims to transform the diagnosis and treatment of endometriosis and adenomyosis by developing innovative imaging tools, creating advanced 3D disease models, and identifying new therapies to reduce pain and improve fertility.
The FEMCHIP consortium is a collaboration between Maastricht University, MUMC+, UMC Utrecht, Amsterdam UMC, and Radboud University. To address the urgent need for better diagnostics and treatments, FEMCHIP collaborates closely with Dutch and international industry partners, patient organizations, and innovation hubs to accelerate solutions for these underserved diseases.
Programme lead: prof. dr. Roman K. Truckenmüller
Co-applicants: dr. ir. P.A.W. Wieringa, dr. ir. E.J. Vrij, dr. Z.N. Tahmasebi Birgani, Jacques Maas, Salwan Al-Nasiry, Andrea Romano, Velja Mijatovic, Judith Huirne, Arjan W. Griffioen, Lynda Juffermans, Bernadette de Bakker, Lennie Van Hanegem, Willem Verpoest, Gaby Steba, Klaas Mulder, prof. dr. M. Vermeulen
Consortium: Endometriose Stichting, Genomics, 300MICRONS GmbH, chiron, CimCure B.V., Fluidnatek and Spinbox by Bioinicia, ibidi GmbH, Little Miracles Foundation, Merck Group, Metatissue, Olink, Optics11 Life, Proefdiervrij, ReGEN Biomedical, Samsung Healthcare, STEMCELL Technologies, Theramex, TNO, and Topigs Norsvin”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG